FIELD: chemical and pharmaceutical industry, in particular vaccine against coypu salmonelasis.
SUBSTANCE: claimed vaccine contains suspension of pure culture cells of Salmonella typhimurium causative agent, obtained by sampling of pathological material from fallen coypus of local epidemical locus, suspension preparation, sowing on differential diagnostic media, isolation of Salmonella typhimurium causative agent pure culture, and culturing in meat-peptone broth with titer of 4-5 bln of microbial cells per 2 cm3. Vaccine also contains glucose, formalin and aluminum hydroxide in the next mass ratio: abovementioned pure culture cells of Salmonella typhimurium causative agent 83.0-86.0; glucose 1.0-2.0; formalin 1.0-2.0; and balance: aluminum hydroxide.
EFFECT: non-toxic vaccine having high reactivity.
5 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| ASSOCIATED VACCINE AGAINST COLIBACTERIOSIS, SALMONELLOSIS, STREPTOCOCCOSIS AND ENTEROCOCCAL INFECTION IN NUTRIAS | 2006 |
|
RU2316344C1 |
| ASSOCIATED VACCINE AGINST SALMONELLOSIS AND COLIBACTERIOSIS | 2005 |
|
RU2292913C1 |
| MIXED VACCINE AGAINST COLI-BACTERIOSIS, SALMONELLOSIS AND ENTROCOCCUS INFECTION IN NUTRIA | 2006 |
|
RU2301078C1 |
| ASSOCIATED VACCINE AGINST SALMONELLOSIS AND STREPTOCOCCOSIS | 2005 |
|
RU2292912C1 |
| MIXED VACCINE AGAINST COLI-BACTERIOSIS, SALMONELLOSIS AND STREPTOCOCCOSUS IN NUTRIA | 2006 |
|
RU2301681C1 |
| VACCINE, ASSOCIATED AGAINST NUTRIA SALMONELLOSIS AND ENTEROCOCCUS INFECTION | 2005 |
|
RU2296583C1 |
| METHOD FOR PREPARING ASSOCIATED VACCINE AGINST SALMONELLOSIS AND ENTEROCOCCAL INFECTION IN NUTRIAS | 2005 |
|
RU2292914C1 |
| METHOD FOR PREPARING ASSOCIATED VACCINE AGINST SALMONELLOSIS AND STREPTOCOCCOSIS IN NUTRIAS | 2005 |
|
RU2292911C1 |
| METHOD OF MANUFACTURING OF VACCINE ASSOCIATED AGAINST COLIBACILLOSIS, SALMONELLOSIS AND ENTEROCOCCUS INFECTIONS OF NUTRIAS | 2006 |
|
RU2338554C2 |
| METHOD FOR PREPARING MIXED VACCINE AGAINST COLI-BACTERIOSIS, SALMONELLOSIS AND STREPTOCOCCOSIS IN NUTRIA | 2006 |
|
RU2301077C1 |
